{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:22:38Z","timestamp":1787656958516,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":96,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Instituto de Salud Carlos III and European Union","award":["CM21\/00081"],"award-info":[{"award-number":["CM21\/00081"]}]},{"name":"Instituto de Salud Carlos III and European Union","award":["CM17\/00015"],"award-info":[{"award-number":["CM17\/00015"]}]},{"name":"Instituto de Salud Carlos III and European Union","award":["FI23\/00089"],"award-info":[{"award-number":["FI23\/00089"]}]},{"name":"Instituto de Salud Carlos III and European Union","award":["PI20\/00609"],"award-info":[{"award-number":["PI20\/00609"]}]},{"name":"Instituto de Salud Carlos III and European Union","award":["PI19\/00036"],"award-info":[{"award-number":["PI19\/00036"]}]},{"name":"Binational Science Foundation","award":["207745"],"award-info":[{"award-number":["207745"]}]},{"name":"US NIH","award":["R01AI144112 and R01AI146917"],"award-info":[{"award-number":["R01AI144112 and R01AI146917"]}]},{"name":"Instituto de Salud Carlos III and European Union","award":["PI22\/00013"],"award-info":[{"award-number":["PI22\/00013"]}]},{"name":"Instituto de Salud Carlos III and European Union","award":["PI22\/00013"],"award-info":[{"award-number":["PI22\/00013"]}]},{"name":"Secretaria d\u2019Universitats i Recerca del Departament d\u2019Economia i Coneixement","award":["2021_SGR_01322"],"award-info":[{"award-number":["2021_SGR_01322"]}]},{"name":"CERCA Programme\/Generalitat de Catalunya"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52234-y","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:34:09Z","timestamp":1779366849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early hepatitis B and delta virus kinetics in patients undergoing liver transplantation"],"prefix":"10.1038","volume":"16","author":[{"given":"Sara","family":"Battistella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pocurull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Leonel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rodr\u00edguez-Tajes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliam","family":"Fundora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Shekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeor","family":"Hershkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Cotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harel","family":"Dahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Fortney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Cloherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Saez-Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabela","family":"Lens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"P\u00e9rez-del-Pulgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"52234_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jhep.2012.10.016","volume":"58","author":"P Burra","year":"2013","unstructured":"Burra, P. et al. Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes. J. Hepatol. 58, 287\u2013296. https:\/\/doi.org\/10.1016\/j.jhep.2012.10.016 (2013).","journal-title":"J. Hepatol."},{"key":"52234_CR2","doi-asserted-by":"publisher","unstructured":"Adam, R. et al. Annual report of the european liver transplant registry (ELTR)\u2009\u2013\u200950-year evolution of liver transplantation. Trans. Int. 31, 293\u2013317. (2018). https:\/\/doi.org\/10.1111\/tri.13358","DOI":"10.1111\/tri.13358"},{"key":"52234_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-6143.2012.04315.x","volume":"13","author":"E Cholongitas","year":"2013","unstructured":"Cholongitas, E. & Papatheodoridis, G. V. High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: A systematic review. Am. J. Transpl. 13, 353\u2013362. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04315.x (2013).","journal-title":"Am. J. Transpl"},{"key":"52234_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/lt.23566","volume":"19","author":"MR Lucey","year":"2013","unstructured":"Lucey, M. R. et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 19, 3\u201326. https:\/\/doi.org\/10.1002\/lt.23566 (2013).","journal-title":"Liver Transpl."},{"key":"52234_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/apt.16374","volume":"54","author":"C Duvoux","year":"2021","unstructured":"Duvoux, C. et al. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation. Aliment. Pharmacol. Ther. 54, 583\u2013605. https:\/\/doi.org\/10.1111\/apt.16374 (2021).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"52234_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","volume":"83","author":"M Cornberg","year":"2025","unstructured":"Cornberg, M. et al. EASL clinical practice guidelines on the management of hepatitis B virus infection. J. Hepatol. 83, 502\u2013583. https:\/\/doi.org\/10.1016\/j.jhep.2025.03.018 (2025).","journal-title":"J. Hepatol."},{"key":"52234_CR7","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","volume":"329","author":"D Samuel","year":"1993","unstructured":"Samuel, D. et al. Liver transplantation in european patients with the hepatitis B surface antigen. N. Engl. J. Med. 329, 1842\u20131847. https:\/\/doi.org\/10.1056\/NEJM199312163292503 (1993).","journal-title":"N. Engl. J. Med."},{"key":"52234_CR8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/lt.21179","volume":"13","author":"M Hussain","year":"2007","unstructured":"Hussain, M., Soldevila-Pico, C., Emre, S., Luketic, V. & Lok, A. S. F. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Transpl. 13, 1137\u20131144. https:\/\/doi.org\/10.1002\/lt.21179 (2007).","journal-title":"Liver Transpl."},{"key":"52234_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.dld.2009.12.003","volume":"42","author":"I Lenci","year":"2010","unstructured":"Lenci, I. et al. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Dig. Liver Disease. 42, 578\u2013584. https:\/\/doi.org\/10.1016\/j.dld.2009.12.003 (2010).","journal-title":"Dig. Liver Disease"},{"key":"52234_CR10","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.jhepr.2023.100728","volume":"5","author":"F Villeret","year":"2023","unstructured":"Villeret, F. et al. Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis. JHEP Rep. 5, 100728. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100728 (2023).","journal-title":"JHEP Rep."},{"key":"52234_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","volume":"67","author":"L Allweiss","year":"2018","unstructured":"Allweiss, L. et al. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo. Gut 67, 542\u2013552. https:\/\/doi.org\/10.1136\/gutjnl-2016-312162 (2018).","journal-title":"Gut"},{"key":"52234_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jviromet.2011.11.001","volume":"179","author":"RB Ferns","year":"2012","unstructured":"Ferns, R. B., Nastouli, E. & Garson, J. A. Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard. J. Virol. Methods. 179, 189\u2013194. https:\/\/doi.org\/10.1016\/j.jviromet.2011.11.001 (2012).","journal-title":"J. Virol. Methods"},{"key":"52234_CR13","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1038\/s41598-017-03946-9","volume":"7","author":"K Giersch","year":"2017","unstructured":"Giersch, K. et al. Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV\/HDV infected humanized mice. Sci. Rep. 7, 3757. https:\/\/doi.org\/10.1038\/s41598-017-03946-9 (2017).","journal-title":"Sci. Rep."},{"key":"52234_CR14","doi-asserted-by":"publisher","unstructured":"Lhomme, S. et al. Plasma hepatitis E virus kinetics in solid organ transplant patients receiving ribavirin. Viruses 11 https:\/\/doi.org\/10.3390\/v11070630 (2019).","DOI":"10.3390\/v11070630"},{"key":"52234_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jhep.2004.12.017","volume":"42","author":"H Dahari","year":"2005","unstructured":"Dahari, H., Feliu, A., Garcia-Retortillo, M., Forns, X. & Neumann, A. U. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation. J. Hepatol. 42, 491\u2013498. https:\/\/doi.org\/10.1016\/j.jhep.2004.12.017 (2005).","journal-title":"J. Hepatol."},{"key":"52234_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0168-8278(97)80035-9","volume":"26","author":"A Brind","year":"1997","unstructured":"Brind, A. et al. Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J. Hepatol. 26, 228\u2013235. https:\/\/doi.org\/10.1016\/S0168-8278(97)80035-9 (1997).","journal-title":"J. Hepatol."},{"key":"52234_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jcmgh.2016.10.003","volume":"3","author":"T Sanada","year":"2017","unstructured":"Sanada, T. et al. Transmission of HBV DNA mediated by ceramide-triggered extracellular vesicles. Cell. Mol. Gastroenterol. Hepatol. 3, 272\u2013283. https:\/\/doi.org\/10.1016\/j.jcmgh.2016.10.003 (2017).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"52234_CR18","doi-asserted-by":"publisher","first-page":"101311","DOI":"10.1016\/j.jhepr.2024.101311","volume":"7","author":"L Shekhtman","year":"2025","unstructured":"Shekhtman L, et al.\u00a0Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes. JHEP Rep.\u00a0\u00a07(4):101311. 10.1016\/j.jhepr.2024.101311. (2025)","journal-title":"JHEP Rep."},{"key":"52234_CR19","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.transproceed.2014.07.043","volume":"46","author":"F Tandoi","year":"2014","unstructured":"Tandoi, F. et al. Minimization of Anti\u2013hepatitis B Surface Antigen Immunoglobulins for Prophylaxis of Hepatitis B Viral Recurrence in the First Month After Liver Transplantation: The Meaning of HBsAg Quantitative Level at the Time of Transplant. Transpl. Proc. 46, 2308\u20132311. https:\/\/doi.org\/10.1016\/j.transproceed.2014.07.043 (2014).","journal-title":"Transpl. Proc."},{"key":"52234_CR20","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1038\/s41598-020-64122-0","volume":"10","author":"L Shekhtman","year":"2020","unstructured":"Shekhtman, L. et al. Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg. Sci. Rep. 10, 7837. https:\/\/doi.org\/10.1038\/s41598-020-64122-0 (2020).","journal-title":"Sci. Rep."},{"key":"52234_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","volume":"81","author":"F Zoulim","year":"2024","unstructured":"Zoulim, F., Chen, P-J., Dandri, M., Kennedy, P. T. & Seeger, C. Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome. J. Hepatol. 81, 1087\u20131099. https:\/\/doi.org\/10.1016\/j.jhep.2024.06.037 (2024).","journal-title":"J. Hepatol."},{"key":"52234_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.antiviral.2016.10.006","volume":"136","author":"D Alfaiate","year":"2016","unstructured":"Alfaiate, D. et al. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes. Antiviral Res. 136, 19\u201331. https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.006 (2016).","journal-title":"Antiviral Res."},{"key":"52234_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1128\/JVI.01609-10","volume":"85","author":"T Pollicino","year":"2011","unstructured":"Pollicino, T. et al. Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. J. Virol. 85, 432\u2013439. https:\/\/doi.org\/10.1128\/JVI.01609-10 (2011).","journal-title":"J. Virol."},{"key":"52234_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.11.051","author":"E Degasperi","year":"2024","unstructured":"Degasperi, E. et al. Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2024.11.051 (2024).","journal-title":"J. Hepatol."},{"key":"52234_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa2213429","volume":"389","author":"H Wedemeyer","year":"2023","unstructured":"Wedemeyer, H. et al. A phase 3, randomized trial of bulevirtide in chronic hepatitis D. N. Engl. J. Med. 389, 22\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2213429 (2023).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52234-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52234-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52234-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:02:12Z","timestamp":1787655732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52234-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52234"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52234-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HD serves as advisor for VIR.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Hospital Clinic institutional Ethics Committee (HCB\/2019\/0710) and was conducted in compliance with the principles of the Declaration of Helsinki, Good Clinical Practice guidelines, and local regulatory requirements.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26566"}}